Skip to main content
Cyfuse Biomedical K.K. (TYO:4892)
Japan flag Japan · Delayed Price · Currency is JPY
977.00
-5.00 (-0.51%)
Apr 28, 2025, 3:30 PM JST

Cyfuse Biomedical K.K. Cash Flow Statement

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Net Income
-869-586-471--
Upgrade
Depreciation & Amortization
384063--
Upgrade
Other Operating Activities
431245--
Upgrade
Change in Accounts Receivable
-3-344--
Upgrade
Change in Inventory
-9-521--
Upgrade
Change in Accounts Payable
22-20-3--
Upgrade
Change in Other Net Operating Assets
18-112-62--
Upgrade
Operating Cash Flow
-760-562-403--
Upgrade
Capital Expenditures
-8-19-228--
Upgrade
Investment in Securities
---200--
Upgrade
Other Investing Activities
---2--
Upgrade
Investing Cash Flow
-8-19-430--
Upgrade
Short-Term Debt Issued
-73328--
Upgrade
Long-Term Debt Issued
--90--
Upgrade
Total Debt Issued
-73418--
Upgrade
Short-Term Debt Repaid
-51----
Upgrade
Long-Term Debt Repaid
-18-77-82--
Upgrade
Total Debt Repaid
-69-77-82--
Upgrade
Net Debt Issued (Repaid)
-69-4336--
Upgrade
Issuance of Common Stock
17222,329--
Upgrade
Other Financing Activities
---7--
Upgrade
Financing Cash Flow
-52182,658--
Upgrade
Miscellaneous Cash Flow Adjustments
-1--1--
Upgrade
Net Cash Flow
-821-5631,824--
Upgrade
Free Cash Flow
-768-581-631--
Upgrade
Free Cash Flow Margin
-1422.22%-952.46%-168.72%--
Upgrade
Free Cash Flow Per Share
-95.40-74.37-236.54--
Upgrade
Cash Interest Paid
997--
Upgrade
Cash Income Tax Paid
222--
Upgrade
Levered Free Cash Flow
-585.25-446.88-458--
Upgrade
Unlevered Free Cash Flow
-579-440.63-453.63--
Upgrade
Change in Net Working Capital
4926235-
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.